Clinical Trials Logo
  1. Home
  2. Hypertension
  3. NCT02150382
  4. Details
NCT02150382 Clinical Trial

China Rural Hypertension Control Project 2014

Hypertension Clinical Trial

Official title:
Effectiveness of a Standardized Protocol-based Treatment Program on Hypertension Control in Rural China.

Clinical Trial Details — Status: Withdrawn

Administrative data
NCT number NCT02150382
Other study ID # China Medical University
Secondary ID
Status Withdrawn
Phase
First received
Last updated
Start date February 2014
Est. completion date October 2016

Study information
Verified date May 2014
Source First Hospital of China Medical University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

China Rural Hypertension Control (CRHC) Project is a cluster randomized trial aims to test the effectiveness of a standardized protocol-based treatment program on hypertension control in rural China.

Recruitment information / eligibility
Status Withdrawn
Enrollment 0
Est. completion date October 2016
Est. primary completion date July 2016
Accepts healthy volunteers No
Gender All
Age group 40 Years and older
Eligibility Inclusion Criteria: - Man and women aged 40 years or older. - Mean systolic blood pressure =140 mm Hg and/or diastolic blood pressure =90 mm Hg; and/or use of antihypertensive medications.Mean blood pressure is based on three measurements at two separate days at least two days apart and within one month. - Permanent residents in the study villages. - Do not plan to emigrate in the next 2 years. Exclusion Criteria: - Unable to provide consent. - Treated for malignant tumor and life expectancy<2 years judged by study physician. - Pregnancy, currently trying to become pregnant, or of child-bearing potential and not using birth control. - Diagnosted psychiatric patients.

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
China First Hospital of China Medical University Shenyang Liaoning

Sponsors (1)
Lead Sponsor Collaborator
First Hospital of China Medical University

Country where clinical trial is conducted

China, 

Outcome
Type Measure Description Time frame Safety issue
Primary a composite outcome of cardiovascular disease and all-cause mortality up to 2-year
Secondary Major cardiovascular diseases up to 2-year
Secondary Fatal and non-fatal stroke up to 2-year
Secondary Fatal and non-fatal myocardial infarction up to 2-year
Secondary Hospitalized or treated heart failure up to 2-year
Secondary Cardiovascular death up to 2-year
Secondary Change in mean systolic and diastolic blood pressure up to 2-year
Secondary Proportion of hypertension control up to 2-year
See also
  Status Clinical Trial Phase
Terminated NCT04591808 - Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia Phase 3
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Completed NCT05491642 - A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses Phase 1
Completed NCT03093532 - A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT05529147 - The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
Recruiting NCT05976230 - Special Drug Use Surveillance of Entresto Tablets (Hypertension)
Recruiting NCT06363097 - Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
Completed NCT06008015 - A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers Phase 1
Completed NCT05387174 - Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period N/A
Completed NCT04082585 - Total Health Improvement Program Research Project
Recruiting NCT05121337 - Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension N/A
Withdrawn NCT04922424 - Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men Phase 1
Active, not recruiting NCT05062161 - Sleep Duration and Blood Pressure During Sleep N/A
Not yet recruiting NCT05038774 - Educational Intervention for Hypertension Management N/A
Completed NCT05087290 - LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
Completed NCT05621694 - Exploring Oxytocin Response to Meditative Movement N/A
Completed NCT05688917 - Green Coffee Effect on Metabolic Syndrome N/A
Recruiting NCT05575453 - OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure N/A